Abstract
Obesity is a risk factor for life-style-related diseases, and is based on three factors: genetic, environmental, and life-style. In adults, it is difficult to achieve and maintain normal body weight, so it is more effective to intervene from infancy to establish weight control. Legally required health checkups in infants of 18 and 36 months present important opportunities for obesity prevention. We consider genetic analysis to be a very important factor for obesity prevention in infancy. However, since health checkups don’t involve the collection of blood, genetic analysis is considered difficult. In this study, we attempted the typing of beta3 adrenergic receptor gene polymorphism as a genetic factor from non-invasively obtained samples, buccal mucosa, hair and cerumen in 96 infants at their 18- and 36-month health checkups. Sampling buccal mucosa, hair and cerumen instead of blood caused almost no anxiety to the child or parent, so 94.1% cooperation with sampling was obtained. From buccal mucosa, about 76% of the samples could be used for the typing of polymorphism (81% by enzyme method, 59% by kit method). From hair, about 44% of the samples permitted typing of polymorphism, but from cerumen only about 4% of the samples could be used. Results from buccal mucosa and hair typed about 90% of infant polymorphism. These results suggest that this method would be practical at periodic health checkups, and would probably be applicable to mass screenings for genetic factor analysis for other diseases.
Similar content being viewed by others
References
Uragami T. Problems in childhood obesity. Clinic All-round 1997; 46: 2156–9. (in Japanese)
Health implications of obesity: National Institutes of Health Consensus Development Conference statement. National Institutes of Health Consensus Development Panel on the health implications of obesity. Ann Intern Med 1985; 103: 1073–7.
Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338: 1–7.
Hirsch J. Pathophysiology of obesity. J Nutr 1997; 127: 1874S.
Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science 1998; 280: 1371–4.
Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998; 280: 1374–7.
Bouchard C. Current understanding of the etiology of obesity: genetic and nongenetic factors. Am J Clin Nutr 1991; 53: 1561S-5S.
NIH Technology Assessment Conference Panel. Methods for voluntary weight loss and control. Ann Intern Med 1993; 119:764–70.
Epstein LH, Valoski AM, Kalarchian MA, McCurley J: Do children lose and maintain weight easier than adults: A comparison of child and parent weight changes from six months to ten years. Obesity Research, 1995; 3: 411–7.
Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997; 337: 869–73.
Kinugasa A, Yamamoto T, Terada N, et al. Retrospective study of body stature of school children in relation to the body habitus in infancy and early childhood. J Child Health 1986; 45: 547–51. (in Japanese)
Kinugasa K, Kinugasa A, Yamamoto T, Sawada T. The relationship of body habitus of early childhood to that of school age-children. J Child Health 1992; 51: 377–82. (in Japanese)
Shapiro LR, Crawford PB, Clark MJ, Pearson DL, Raz J, Huenemann RL. Obesity prognosis: A longitudinal study of children from the age of 6 month to 9 years. Am J Public Health 1984; 74: 968–72.
Guo SS, Roche AF, Chumlea WC, Gardner JD, Siervogel RM. The predictive value of childhood body mass index values for overweight at age 35y. Am J Clin Nutr 1994; 59: 810–9.
Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T. Do obese children become obese adults? A review of the literature. Prev Med 1993; 22: 167–77.
Court JM, Dunlop M: Obese from infancy; A clinical entity. In: Recent Advances in Obesity Research I. Proc. 1st International Congress on Obesity, p34, Newman Publishing Ltd., London, 1975.
Klesges RC, Klesges LM, Eck LM, Shelton ML. A longitudinal analysis of accelerated weight gain in preschool children. Pediatrics 1995; 95: 126–30.
Ohhashi A, Aoki T, Matsugo S, Simasaki C. PCR-based typing of human buccal cell’s DNA extracted from whole saliva stains. Jap J of Legal Med. 1993; 47: 108–18. (in Japanese)
Higuchi R, Beroldingen CH, Sensabaugh GF, Erlich HA. DNA typing from single hairs. Nature 1988; 332: 543–46.
Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in theβ3- adrenergic-receptor gene with feature of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348–51.
Matsuda K. Pin-point sequencing - A rapid method for detecting gene polymorphisms / mutations. J Clinical Experimental Medicine 1998; 184: 654–8. (in Japanese)
Yuan X, Yamada K, Koyama K, et al. Beta 3-adrenergic receptor gene polymorphism is not a major genetic determinant of obesity and diabetes in Japanese general population. Diabetes Res Clin Pract 1997; 37(1): 1–7.
Motoyama HK, Yasuda K, Yamaguchi T, et al. A mutation of the β 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 1997; 40: 469–72.
Yoshida T, Sakane N, Umekawa T, Sakai M, Takahashi T, Kondo M. Mutation of β3-adrenergic-receptor gene and response to treatment of obesity. The Lancet 1995; 346: 1443–4.
Sakane N, Yoshida T, Kogure K, Takakura Y, Umekawa T, Kondo M. Effects of Trp64Arg mutation in the β3- adrenergic-receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care 1997; 20: 1887–90.
Clement K, Vaisse C, Manning BSJ, et al. Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352–4.
Sipiläinen R, Uusitupa M, Heikkinen S, Rissanen A, Laakso M. Polymorphism of theβ3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes 1997; 46: 77–80.
Sakane N, Yoshida T, Umekawa T, Kondo M, Sakai Y, Takahashi T. β3-adrenergic-receptor polymorphism: A genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia 1997; 40: 200–4.
Friedman JM. The alphabet of weight control. Nature 1997; 385: 119–20.
Kern PA. Potential role of TNF α and lipoprotein lipase as candidate genes for obesity. J Nutr 1997; 127: 1917S-22S.
Weigle DS, Kuijper JL. Obesity genes and the regulation of body fat content. Bioessays 1996; 18: 867–74.
Jackson RS, Creemers JWM, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997; 16:303–6.
Roberts SB. Human obesity genes. Nutrition 1997; 13(3): 236–8.
Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387; 903–8.
Rissanen J, Vanhala M, Kuopusjärvi M, et al. The Trp64Arg polymorphism of the β3-adrenergic receptor gene. Diabetes Care 1997; 20: 1319–23.
Ueda K, Tanizawa Y, Oota Y, et al. Prevalence of the Trp64Arg missense mutation of theβ3-adrenergic receptor gene in Japanese subjects. Metabolism 1997; 46: 199–202.
Wilson JMG, Jungner F. Principles and practice of screening for disease (Public Health Papers No.34). WHO, Geneva, 1968.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tadokoro, M., Sato, C., Takeda, N. et al. Analysis of beta3 adrenergic receptor gene polymorphism using noninvasive samples obtained at scheduled infant health checkups.. Environ Health Prev Med 4, 190–198 (2000). https://doi.org/10.1007/BF02931257
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02931257